Patents by Inventor Robert Shutter

Robert Shutter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180291412
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances. Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Application
    Filed: June 21, 2018
    Publication date: October 11, 2018
    Inventors: Diane M. Retallack, Charles H. Squires, David C. Watkins, Stacey L. Lee, Frank H. Gaertner, Robert Shutter
  • Patent number: 10041102
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances. Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: August 7, 2018
    Assignee: PFENEX INC.
    Inventors: Diane M. Retallack, Charles H. Squires, David C. Watkins, Stacey L. Lee, Frank H. Gaertner, Robert Shutter
  • Publication number: 20170051327
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable Circumstances Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Application
    Filed: August 5, 2016
    Publication date: February 23, 2017
    Inventors: Diane M. Retallack, Charles H. Squires, David C. Watkins, Stacey L. Lee, Frank H. Gaertner, Robert Shutter
  • Patent number: 9458487
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: October 4, 2016
    Assignee: PFENEX, INC.
    Inventors: Diane M. Retallack, Charles H. Squires, David C. Watkins, Stacey L. Lee, Frank H. Gaertner, Robert Shutter
  • Patent number: 9453251
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: September 27, 2016
    Assignee: PFENEX INC.
    Inventors: Diane M. Retallack, Charles H. Squires, David C. Watkins, Stacey L. Lee, Frank H. Gaertner, Robert Shutter
  • Publication number: 20060234346
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Application
    Filed: April 7, 2006
    Publication date: October 19, 2006
    Inventors: Diane Retallack, Charles Squires, David Watkins, Stacey Lee, Frank Gaertner, Robert Shutter
  • Publication number: 20060040352
    Abstract: The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances Processes for improved production of isolated mammalian, particularly human, proteins are provided.
    Type: Application
    Filed: January 18, 2005
    Publication date: February 23, 2006
    Inventors: Diane Retallack, Charles Squires, David Watkins, Stacey Lee, Frank Gaertner, Robert Shutter